Adeptrix Corporation s structured around development and manufacture of analytical reagents and assays based on the companys proprietary platform technology designated Bead Assisted Mass Spectrometry (BAMS). BAMS is an innovative and powerful analytical platform enabling immunoassays to be measured by MALDI mass spectrometry for rapid, precise and sensitive target analyte detection. The BAMS platform technology is both (1) multiplexed -- capable of measuring multiple target analytes in a single assay -- and (2) high-throughput: capable of measuring hundreds to thousands of assays per day. These two factors make the system of va;lue and utility in a wide range of bio-analytical applications in drug development, basic research and clinical diagnostics.
